Intravenous cidofovir for diffuse genital warts in the setting of multifactorial immunosuppression.

Blaizot, R; Dutkiewicz, A-S; Guillet, S; Pham-Ledard, A; Beylot-Barry, M

Blaizot, R; Dutkiewicz, A-S; Guillet, S; Pham-Ledard, A; Beylot-Barry, M.

Affiliation

Blaizot R; Dermatology Department, Oncodermatology Unit, CHU de Bordeaux, University of Bordeaux, Bordeaux, France.
Dutkiewicz AS; Dermatology Department, Oncodermatology Unit, CHU de Bordeaux, University of Bordeaux, Bordeaux, France.
Guillet S; Dermatology Department, Oncodermatology Unit, CHU de Bordeaux, University of Bordeaux, Bordeaux, France.
Pham-Ledard A; Dermatology Department, Oncodermatology Unit, CHU de Bordeaux, University of Bordeaux, Bordeaux, France.
Beylot-Barry M; Dermatology Department, Oncodermatology Unit, CHU de Bordeaux, University of Bordeaux, Bordeaux, France.

J Eur Acad Dermatol Venereol ; 31(3): e162-e163, 2017 Mar.

Article in En | MEDLINE | ID: mdl-27527116

Subject(s)

Cidofovir/administration & dosage; Condylomata Acuminata/drug therapy; Male Urogenital Diseases/drug therapy; Antiviral Agents/administration & dosage; Condylomata Acuminata/diagnosis; Humans; Injections, Intravenous; Male; Male Urogenital Diseases/diagnosis; Middle Aged

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Condylomata Acuminata / Male Urogenital Diseases / Cidofovir Type of study: Diagnostic_studies Limits: Humans / Male / Middle aged Language: En Journal: J Eur Acad Dermatol Venereol Journal subject: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Year: 2017 Document type: Article Affiliation country: France Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google